Skip to main content

Table 19 Critical appraisal of qualitative studies supporting Theme #4: emotional and psychological impact of not receiving take-home doses

From: The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review

No

Study

MMAT Sect. 1a for qualitative studies

1

2

3

4

5

Is the qualitative approach appropriate to answer the research question?

Are the qualitative data collection methods adequate to address the research question?

Are the findings adequately derived from the data?

Is the interpretation of results sufficiently substantiated by data?

Is there coherence between qualitative data sources, collection, analysis and interpretation?

S1

Abidogun et al., 2023 [69]

Yes

Yes

Yes

Yes

Yes

S14

Harris et al., 2022 [82]

Yes

Yes

Yes

Yes

Yes

S15

Hoffman et al., 2022 [83]

Yes

Yes

Yes

Yes

Yes

S18

Kesten et al., 2021 [86]

Yes

Yes

Yes

Yes

Yes

S19

Krawczyk et al., 2021 [87]

Yes

Yes

Yes

Yes

Yes

S20

Levander et al., 2021 [88]

Yes

Yes

Yes

Yes

Yes

S21

Liddell et al., 2021 [89]

Yes

Yes

Can't tell

Yes

Yes

S24

Meyerson et al., 2022 [92]

Yes

Yes

Can't tell

Can't tell

Can't tell

S34

Scott et al., 2023 [102]

Yes

Yes

Yes

Yes

Yes

S35

Suen et al., 2022/Wyatt et al., 2022 [104]

Yes

Yes

Yes

Yes

Yes

S38

Walters et al., 2022 [108]

Yes

Yes

Yes

Yes

Yes

S40

Zhen-Duan et al., 2022 [110]

Yes

Yes

Yes

Yes

Yes

# meeting quality criteria

12/12

12/12

10/12

11/12

11/12

  1. aThe MMAT (Mixed Methods Appraisal Tool) Qualitative Checklist is designed specifically for mixed methods systematic reviews (Hong et al., 2018). It consists of five sections specific to various study designs, each with five quality criteria. All qualitative studies included in this review including qualitative components of mixed-methods studies, were appraised under Sect. 1: Qualitative studies